EUVIMEDEUVIMED entdecken
Open Access

Research on the role and mechanism of SLC7A5 in idiopathic pulmonary fibrosis

Menghan Wang, Yao Yu, Zhaoyu Liu, Dandan Xu, Yupeng Li, Xing Zou, Ning Shan, Xining Liu, Ce Shi, Hong Chen

Molecular Medicine Reports · 2026

DOI: 10.3892/mmr.2026.14034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Medicine Reports, 2026. Verfasst von Menghan Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. Ch…. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Minor Histocompatibility Antigens, Amino Acid Transport System y+. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is a progressive, chronic and fatal interstitial lung disease. The etiology of IPF remains to be fully elucidated and its prognosis remains poor with a short survival period. Solute carrier family 7 member 5 (SLC7A5) is an amino acid transporter that is responsible for the transportation of large neutral amino acids. The expression of SLC7A5 was found to be significantly upregulated in patients with IPF, as well as in the lung tissues of mice with bleomycin (BLM)‑induced pulmonary fibrosis and in human lung fibroblasts induced by transforming growth factor‑β1 (TGF‑β1). Both SLC7A5 knockdown and the use of the selective SLC7A5 inhibitor JPH203 affected the function of TGF‑β1‑induced myofibroblasts by inhibiting the PI3K/AKT/mTOR pathway. In vivo, JPH203 improved BLM‑induced pulmonary fibrosis in mice by inhibiting the activation of the PI3K/AKT/mTOR signaling pathway. Therefore, SLC7A5 may represent a new therapeutic target for IPF. Future research should focus on therapeutic strategies regulating this target for translation into potential effective treatments for IPF in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisMinor Histocompatibility AntigensAmino Acid Transport System y+AnimalsHumansSignal TransductionBleomycinTOR Serine-Threonine KinasesMiceProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesTransforming Growth Factor beta1Disease Models, AnimalFibroblastsMaleLungMyofibroblastsLarge Neutral Amino Acid-Transporter 1

Stichwörter der Autor:innen

JPH203PI3K/AKT/mTOR signaling pathwayidiopathic pulmonary fibrosissolute carrier family 7 member 5

Substanzen

BleomycinTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesSLC7A5 protein, humanTransforming Growth Factor beta1Minor Histocompatibility AntigensAmino Acid Transport System y+Large Neutral Amino Acid-Transporter 1

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China.
  • Department of Respiratory Medicine, Heilongjiang Provincial Hospital, Harbin, Heilongjiang 150001, P.R. China.
  • NHC Key Laboratory of Cell Transplantation, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.

Zitieren

APA

Wang, M., Yu, Y., Liu, Z., Xu, D., Li, Y., Zou, X., Shan, N., Liu, X., Shi, C., & Chen, H. (2026). Research on the role and mechanism of SLC7A5 in idiopathic pulmonary fibrosis. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2026.14034

Vancouver

Wang M, Yu Y, Liu Z, Xu D, Li Y, Zou X, et al. Research on the role and mechanism of SLC7A5 in idiopathic pulmonary fibrosis. Molecular Medicine Reports. 2026. doi:10.3892/mmr.2026.14034

BibTeX
@article{Wang2026,
  author = {Wang, Menghan and Yu, Yao and Liu, Zhaoyu and Xu, Dandan and Li, Yupeng and Zou, Xing and Shan, Ning and Liu, Xining and Shi, Ce and Chen, Hong},
  title = {Research on the role and mechanism of SLC7A5 in idiopathic pulmonary fibrosis},
  journal = {Molecular Medicine Reports},
  year = {2026},
  doi = {10.3892/mmr.2026.14034}
}
Kostenlos starten →